MARS: Markov Molecular Sampling for Multi-objective Drug DiscoveryDownload PDF

28 Sep 2020 (modified: 25 Jan 2021)ICLR 2021 SpotlightReaders: Everyone
  • Abstract: Searching for novel molecules with desired chemical properties is crucial in drug discovery. Existing work focuses on developing deep generative models to generate either sequences or chemical molecular graphs. However, it remains a great challenge to find novel and diverse compounds satisfying many properties. In this paper, we propose MARS, a method for multi-objective drug molecule discovery. MARS is based on the idea of generating the chemical candidates by iterative editing fragments of molecular graphs. To search for the best candidates, it employs an annealing scheme together with Markov chain Monte Carlo sampling (MCMC) on molecules. To further improve sample efficiency, MARS is equipped with a graph neural network (GNN) as the proposal for candidate edits on molecules, while the GNN is trained on-the-fly utilizing the sample paths in MCMC. Our experiments show that MARS achieves state-of-the-art performance in various multi-objective settings where molecular bio-activity, drug-likeness, and synthesizability are simultaneously considered. In the most challenging setting where four objectives – bio-activities to two different targets, drug-likeness and synthesizability – are simultaneously considered, our method outperforms the state-of-the-art significantly in a comprehensive evaluation.
  • Code Of Ethics: I acknowledge that I and all co-authors of this work have read and commit to adhering to the ICLR Code of Ethics
  • Supplementary Material: zip
19 Replies